These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 1351271)

  • 21. Short-term plasticity at inhibitory synapses in rat striatum and its effects on striatal output.
    Fitzpatrick JS; Akopian G; Walsh JP
    J Neurophysiol; 2001 May; 85(5):2088-99. PubMed ID: 11353025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
    Celada P; Paladini CA; Tepper JM
    Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic and cholinergic stimulation of the ventrolateral striatum elicit rat jaw movements that are funnelled via distinct efferents.
    Adachi K; Hasegawa M; Fujita S; Sato M; Miwa Y; Ikeda H; Koshikawa N; Cools AR
    Eur J Pharmacol; 2002 May; 442(1-2):81-92. PubMed ID: 12020685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A; Yamaguchi T; Kato T
    Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences.
    Harsing LG; Zigmond MJ
    Neuroscience; 1997 Mar; 77(2):419-29. PubMed ID: 9472401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W; Ding S; Zhou FM
    J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones.
    Lacey MG; Mercuri NB; North RA
    J Physiol; 1988 Jul; 401():437-53. PubMed ID: 2459376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of the amygdala and nucleus accumbens to ventral pallidal responses to dopamine agonists.
    Napier TC
    Synapse; 1992 Feb; 10(2):110-9. PubMed ID: 1350111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons.
    Waszczak BL
    Brain Res; 1990 Apr; 513(1):125-35. PubMed ID: 2140951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of GABA systems in feedback regulation of glutamate-and GABA-mediated synaptic potentials in rat neostriatum.
    Calabresi P; Mercuri NB; De Murtas M; Bernardi G
    J Physiol; 1991; 440():581-99. PubMed ID: 1666654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
    Cole DG; Kobierski LA; Konradi C; Hyman SE
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective blockade of a slowly inactivating potassium current in striatal neurons by (+/-) 6-chloro-APB hydrobromide (SKF82958).
    Nisenbaum ES; Mermelstein PG; Wilson CJ; Surmeier DJ
    Synapse; 1998 Jul; 29(3):213-24. PubMed ID: 9635891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent morphine administration induces a long-lasting synergistic effect of corticosterone on dopamine D1 receptor functioning in rat striatal GABA neurons.
    Schoffelmeer AN; De Vries TJ; Vanderschuren LJ; Tjon GH; Nestby P; Wardeh G; Mulder AH
    Synapse; 1997 Apr; 25(4):381-8. PubMed ID: 9097397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons.
    Pisani A; Bonsi P; Centonze D; Calabresi P; Bernardi G
    J Neurosci; 2000 Apr; 20(7):RC69. PubMed ID: 10729358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
    Heidenreich BA; Mitrovic I; Battaglia G; Napier TC
    Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous dopamine and dopaminergic agonists modulate synaptic excitation in neostriatum: intracellular studies from naive and catecholamine-depleted rats.
    Calabresi P; Benedetti M; Mercuri NB; Bernardi G
    Neuroscience; 1988 Oct; 27(1):145-57. PubMed ID: 2904663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terminal excitability of the corticostriatal pathway. I. Regulation by dopamine receptor stimulation.
    Garcia-Munoz M; Young SJ; Groves PM
    Brain Res; 1991 Jun; 551(1-2):195-206. PubMed ID: 1913151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum.
    Meschler JP; Howlett AC
    Neuropharmacology; 2001 Jun; 40(7):918-26. PubMed ID: 11378162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D1-like receptor activation excites rat striatal large aspiny neurons in vitro.
    Aosaki T; Kiuchi K; Kawaguchi Y
    J Neurosci; 1998 Jul; 18(14):5180-90. PubMed ID: 9651201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.